Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neutrophils | 70 | 2024 | 3782 | 9.880 |
Why?
|
Microfluidic Analytical Techniques | 52 | 2021 | 789 | 7.550 |
Why?
|
Chemotaxis | 22 | 2023 | 598 | 5.630 |
Why?
|
Microfluidics | 35 | 2023 | 650 | 5.610 |
Why?
|
Chemotaxis, Leukocyte | 19 | 2023 | 661 | 4.040 |
Why?
|
Cell Movement | 38 | 2024 | 5204 | 3.610 |
Why?
|
Chemotactic Factors | 10 | 2024 | 197 | 2.900 |
Why?
|
Burns | 12 | 2025 | 1902 | 2.300 |
Why?
|
Lab-On-A-Chip Devices | 7 | 2023 | 426 | 1.930 |
Why?
|
Candida albicans | 7 | 2024 | 377 | 1.800 |
Why?
|
Docosahexaenoic Acids | 8 | 2025 | 915 | 1.780 |
Why?
|
Aspergillus fumigatus | 4 | 2024 | 158 | 1.730 |
Why?
|
Sepsis | 9 | 2025 | 2604 | 1.710 |
Why?
|
Leukocytes | 8 | 2019 | 2034 | 1.350 |
Why?
|
Monocytes | 5 | 2025 | 2599 | 1.210 |
Why?
|
Spheroids, Cellular | 2 | 2021 | 328 | 1.180 |
Why?
|
Megakaryocytes | 2 | 2023 | 557 | 1.130 |
Why?
|
Aspergillosis | 3 | 2024 | 242 | 1.080 |
Why?
|
Microinjections | 2 | 2017 | 319 | 1.070 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 5 | 2018 | 221 | 1.020 |
Why?
|
Staphylococcus aureus | 4 | 2022 | 1429 | 0.910 |
Why?
|
Antifungal Agents | 3 | 2024 | 769 | 0.890 |
Why?
|
Blood | 3 | 2019 | 598 | 0.840 |
Why?
|
tau Proteins | 5 | 2021 | 2106 | 0.810 |
Why?
|
Complement C5a | 3 | 2021 | 100 | 0.800 |
Why?
|
Candidiasis | 5 | 2024 | 372 | 0.790 |
Why?
|
Hyphae | 3 | 2021 | 52 | 0.780 |
Why?
|
Nipecotic Acids | 1 | 2021 | 36 | 0.770 |
Why?
|
Complement Inactivating Agents | 1 | 2021 | 53 | 0.760 |
Why?
|
Interleukin-8 | 4 | 2018 | 703 | 0.750 |
Why?
|
Actinomyces | 1 | 2021 | 41 | 0.730 |
Why?
|
Antibiosis | 1 | 2021 | 46 | 0.720 |
Why?
|
Glutamine | 1 | 2023 | 575 | 0.710 |
Why?
|
Streptococcus | 1 | 2021 | 197 | 0.700 |
Why?
|
Neutrophil Infiltration | 3 | 2024 | 392 | 0.700 |
Why?
|
Cell Separation | 9 | 2016 | 1718 | 0.700 |
Why?
|
Host-Pathogen Interactions | 2 | 2020 | 1466 | 0.700 |
Why?
|
Leukocyte Disorders | 2 | 2022 | 12 | 0.690 |
Why?
|
Blood Platelets | 3 | 2023 | 2465 | 0.670 |
Why?
|
Phagocytosis | 10 | 2024 | 1526 | 0.670 |
Why?
|
Dimethyl Sulfoxide | 1 | 2021 | 250 | 0.670 |
Why?
|
Complement Activation | 1 | 2021 | 447 | 0.670 |
Why?
|
Deoxyribonucleases | 2 | 2018 | 209 | 0.670 |
Why?
|
Fungi | 2 | 2021 | 346 | 0.660 |
Why?
|
High-Throughput Screening Assays | 4 | 2018 | 938 | 0.650 |
Why?
|
Borrelia burgdorferi | 1 | 2021 | 183 | 0.640 |
Why?
|
Zebrafish | 5 | 2019 | 3035 | 0.640 |
Why?
|
Tissue Array Analysis | 2 | 2018 | 545 | 0.640 |
Why?
|
Models, Biological | 8 | 2020 | 9464 | 0.610 |
Why?
|
Cell Communication | 6 | 2020 | 1660 | 0.600 |
Why?
|
Colloids | 1 | 2018 | 125 | 0.600 |
Why?
|
Tretinoin | 1 | 2021 | 524 | 0.580 |
Why?
|
Inflammation | 17 | 2022 | 10863 | 0.580 |
Why?
|
Dictyostelium | 2 | 2017 | 70 | 0.550 |
Why?
|
Amyloid beta-Peptides | 6 | 2021 | 3886 | 0.540 |
Why?
|
Time-Lapse Imaging | 4 | 2020 | 194 | 0.540 |
Why?
|
Hepatic Insufficiency | 1 | 2016 | 14 | 0.530 |
Why?
|
Cell Migration Assays, Leukocyte | 1 | 2016 | 8 | 0.530 |
Why?
|
Alzheimer Disease | 10 | 2023 | 8715 | 0.530 |
Why?
|
Biofilms | 1 | 2021 | 641 | 0.520 |
Why?
|
Aniline Compounds | 1 | 2021 | 1079 | 0.520 |
Why?
|
Streptavidin | 1 | 2015 | 81 | 0.510 |
Why?
|
Humans | 136 | 2025 | 766812 | 0.510 |
Why?
|
Biological Assay | 2 | 2018 | 626 | 0.500 |
Why?
|
Rats, Wistar | 5 | 2018 | 1887 | 0.500 |
Why?
|
HL-60 Cells | 6 | 2021 | 364 | 0.500 |
Why?
|
Cytoplasm | 1 | 2020 | 1505 | 0.490 |
Why?
|
Lyme Disease | 1 | 2021 | 627 | 0.480 |
Why?
|
Biotin | 1 | 2015 | 255 | 0.470 |
Why?
|
Organoids | 2 | 2018 | 740 | 0.470 |
Why?
|
Cells, Cultured | 17 | 2021 | 18986 | 0.460 |
Why?
|
Dystonia Musculorum Deformans | 2 | 2014 | 158 | 0.460 |
Why?
|
Equipment Design | 12 | 2018 | 3488 | 0.440 |
Why?
|
Erythrocytes | 8 | 2023 | 2412 | 0.420 |
Why?
|
Models, Immunological | 1 | 2015 | 517 | 0.420 |
Why?
|
Microchemistry | 3 | 2008 | 54 | 0.410 |
Why?
|
Immune System | 1 | 2018 | 800 | 0.410 |
Why?
|
Capillaries | 1 | 2016 | 755 | 0.400 |
Why?
|
Cryopreservation | 4 | 2011 | 727 | 0.400 |
Why?
|
Cytoskeleton | 7 | 2019 | 1179 | 0.400 |
Why?
|
Immune System Diseases | 1 | 2014 | 253 | 0.400 |
Why?
|
Blood Chemical Analysis | 2 | 2016 | 434 | 0.390 |
Why?
|
Interleukin-1 | 1 | 2015 | 1251 | 0.380 |
Why?
|
Epithelial Cells | 3 | 2014 | 3698 | 0.380 |
Why?
|
Internationality | 1 | 2016 | 1006 | 0.360 |
Why?
|
Myosin Type II | 2 | 2021 | 71 | 0.350 |
Why?
|
Cell Migration Assays | 2 | 2012 | 22 | 0.350 |
Why?
|
Renal Insufficiency | 1 | 2016 | 811 | 0.350 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2014 | 754 | 0.340 |
Why?
|
Brain | 6 | 2021 | 27158 | 0.340 |
Why?
|
Signal Transduction | 15 | 2024 | 23618 | 0.330 |
Why?
|
Cell Line | 13 | 2023 | 15564 | 0.330 |
Why?
|
Single-Cell Analysis | 2 | 2018 | 2535 | 0.330 |
Why?
|
T-Lymphocytes | 4 | 2015 | 10263 | 0.330 |
Why?
|
Histones | 1 | 2020 | 2595 | 0.330 |
Why?
|
Immunity, Innate | 7 | 2023 | 3079 | 0.330 |
Why?
|
Cytokines | 8 | 2021 | 7438 | 0.320 |
Why?
|
Epidermal Growth Factor | 1 | 2012 | 697 | 0.320 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2024 | 892 | 0.320 |
Why?
|
Blood-Brain Barrier | 1 | 2015 | 1028 | 0.320 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 488 | 0.310 |
Why?
|
Neurons | 7 | 2023 | 9515 | 0.310 |
Why?
|
Serum | 1 | 2009 | 206 | 0.310 |
Why?
|
Gene Expression Profiling | 7 | 2018 | 9528 | 0.310 |
Why?
|
Electronics | 1 | 2009 | 315 | 0.290 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2210 | 0.290 |
Why?
|
Neoplasms | 7 | 2023 | 22350 | 0.290 |
Why?
|
Ice | 3 | 2004 | 102 | 0.280 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1895 | 0.280 |
Why?
|
Lipoxins | 3 | 2015 | 419 | 0.280 |
Why?
|
Gene Expression | 3 | 2018 | 7585 | 0.280 |
Why?
|
Animals | 46 | 2022 | 168939 | 0.280 |
Why?
|
Leukocyte Count | 2 | 2018 | 1606 | 0.280 |
Why?
|
Larva | 3 | 2017 | 511 | 0.270 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2008 | 335 | 0.270 |
Why?
|
Rats | 8 | 2018 | 23717 | 0.270 |
Why?
|
Cell Line, Tumor | 16 | 2024 | 17089 | 0.270 |
Why?
|
Reactive Oxygen Species | 4 | 2024 | 2144 | 0.270 |
Why?
|
Microglia | 3 | 2019 | 1370 | 0.260 |
Why?
|
Cryoprotective Agents | 2 | 2021 | 123 | 0.260 |
Why?
|
Blood Preservation | 2 | 2017 | 169 | 0.260 |
Why?
|
Leukotriene B4 | 3 | 2021 | 281 | 0.250 |
Why?
|
Cerebrovascular Circulation | 1 | 2015 | 2671 | 0.250 |
Why?
|
Exosomes | 1 | 2009 | 417 | 0.240 |
Why?
|
Micromanipulation | 1 | 2005 | 53 | 0.240 |
Why?
|
Systemic Inflammatory Response Syndrome | 4 | 2022 | 621 | 0.240 |
Why?
|
Eukaryotic Cells | 1 | 2006 | 192 | 0.240 |
Why?
|
Eicosapentaenoic Acid | 3 | 2015 | 565 | 0.230 |
Why?
|
RNA | 5 | 2011 | 2715 | 0.230 |
Why?
|
Clinical Laboratory Techniques | 2 | 2011 | 746 | 0.230 |
Why?
|
Membranes, Artificial | 1 | 2006 | 363 | 0.230 |
Why?
|
Fibroblasts | 2 | 2014 | 4166 | 0.230 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2024 | 4349 | 0.220 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2024 | 258 | 0.220 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2513 | 0.220 |
Why?
|
Cells | 1 | 2004 | 162 | 0.210 |
Why?
|
Lipopolysaccharides | 2 | 2025 | 2215 | 0.210 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2024 | 175 | 0.210 |
Why?
|
Cell Size | 3 | 2018 | 625 | 0.210 |
Why?
|
Cell-Derived Microparticles | 2 | 2016 | 159 | 0.210 |
Why?
|
Skin | 5 | 2021 | 4499 | 0.210 |
Why?
|
Blood Cell Count | 3 | 2019 | 405 | 0.210 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2022 | 28 | 0.210 |
Why?
|
Candida | 2 | 2021 | 174 | 0.200 |
Why?
|
Microarray Analysis | 2 | 2020 | 751 | 0.200 |
Why?
|
Mitochondria | 2 | 2013 | 3678 | 0.200 |
Why?
|
Complement C3-C5 Convertases | 1 | 2021 | 30 | 0.200 |
Why?
|
Basidiomycota | 1 | 2021 | 17 | 0.190 |
Why?
|
Equipment and Supplies | 1 | 2004 | 273 | 0.190 |
Why?
|
Cell Culture Techniques | 4 | 2018 | 1646 | 0.190 |
Why?
|
Cell Aggregation | 3 | 2021 | 238 | 0.190 |
Why?
|
Plaque, Amyloid | 2 | 2018 | 769 | 0.190 |
Why?
|
P-Selectin | 3 | 2016 | 598 | 0.190 |
Why?
|
G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 9 | 0.190 |
Why?
|
Staphylococcal Infections | 2 | 2022 | 1396 | 0.190 |
Why?
|
Biological Phenomena | 1 | 2021 | 27 | 0.190 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2021 | 87 | 0.190 |
Why?
|
Necrosis | 2 | 2018 | 1614 | 0.180 |
Why?
|
Neoplastic Cells, Circulating | 5 | 2017 | 949 | 0.180 |
Why?
|
Cell Polarity | 4 | 2021 | 637 | 0.180 |
Why?
|
Complement C5 | 1 | 2021 | 104 | 0.180 |
Why?
|
Ascomycota | 1 | 2021 | 82 | 0.180 |
Why?
|
Nanotechnology | 3 | 2012 | 702 | 0.180 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.180 |
Why?
|
Inflammation Mediators | 3 | 2016 | 1889 | 0.180 |
Why?
|
Nanostructures | 1 | 2006 | 549 | 0.180 |
Why?
|
Microtubules | 3 | 2013 | 1063 | 0.180 |
Why?
|
Tauopathies | 2 | 2018 | 325 | 0.180 |
Why?
|
Green Fluorescent Proteins | 6 | 2018 | 2062 | 0.180 |
Why?
|
Microtubule-Associated Proteins | 2 | 2018 | 1073 | 0.180 |
Why?
|
Interleukin-1beta | 2 | 2025 | 1026 | 0.170 |
Why?
|
Cryoelectron Microscopy | 1 | 2004 | 645 | 0.170 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4618 | 0.170 |
Why?
|
Freezing | 4 | 2009 | 310 | 0.170 |
Why?
|
Stress, Mechanical | 2 | 2018 | 1674 | 0.170 |
Why?
|
Complement C3 | 1 | 2021 | 434 | 0.170 |
Why?
|
Organ Transplantation | 2 | 2021 | 1172 | 0.170 |
Why?
|
Time Factors | 16 | 2016 | 40149 | 0.170 |
Why?
|
Models, Theoretical | 6 | 2020 | 3563 | 0.160 |
Why?
|
Helicobacter pylori | 1 | 2022 | 380 | 0.160 |
Why?
|
Biosensing Techniques | 1 | 2005 | 641 | 0.160 |
Why?
|
Stochastic Processes | 2 | 2010 | 359 | 0.150 |
Why?
|
Toll-Like Receptors | 1 | 2022 | 582 | 0.150 |
Why?
|
Coculture Techniques | 2 | 2021 | 1337 | 0.150 |
Why?
|
Adenine | 1 | 2024 | 993 | 0.150 |
Why?
|
Mouth | 1 | 2021 | 383 | 0.150 |
Why?
|
Adult | 18 | 2025 | 223305 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 2 | 2020 | 2470 | 0.150 |
Why?
|
Mycoses | 1 | 2021 | 389 | 0.150 |
Why?
|
Immunity | 2 | 2021 | 1002 | 0.150 |
Why?
|
Leukocyte Elastase | 1 | 2018 | 113 | 0.150 |
Why?
|
Microtechnology | 1 | 2018 | 64 | 0.150 |
Why?
|
Neural Stem Cells | 2 | 2018 | 895 | 0.150 |
Why?
|
Phenotype | 4 | 2024 | 16722 | 0.140 |
Why?
|
Male | 30 | 2025 | 364154 | 0.140 |
Why?
|
Critical Illness | 3 | 2018 | 2750 | 0.140 |
Why?
|
Laboratory Animal Science | 1 | 2017 | 9 | 0.140 |
Why?
|
Wound Healing | 4 | 2012 | 2800 | 0.140 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2020 | 633 | 0.140 |
Why?
|
Chromatin | 2 | 2022 | 2980 | 0.140 |
Why?
|
Cell Tracking | 1 | 2018 | 139 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2413 | 0.140 |
Why?
|
Length of Stay | 2 | 2025 | 6491 | 0.140 |
Why?
|
Carrier Proteins | 2 | 2023 | 4926 | 0.140 |
Why?
|
Glutamate Decarboxylase | 1 | 2018 | 239 | 0.140 |
Why?
|
Molecular Chaperones | 2 | 2014 | 760 | 0.140 |
Why?
|
Peroxidase | 1 | 2020 | 610 | 0.140 |
Why?
|
Chemokine CXCL10 | 2 | 2015 | 311 | 0.140 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2018 | 367 | 0.140 |
Why?
|
Pseudomonas Infections | 1 | 2021 | 622 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 895 | 0.140 |
Why?
|
Pseudomonas aeruginosa | 2 | 2021 | 1276 | 0.130 |
Why?
|
Anti-Inflammatory Agents | 3 | 2015 | 1805 | 0.130 |
Why?
|
Mice | 24 | 2022 | 81898 | 0.130 |
Why?
|
Ficoll | 1 | 2016 | 39 | 0.130 |
Why?
|
Young Adult | 11 | 2021 | 59939 | 0.130 |
Why?
|
Cell Survival | 5 | 2017 | 5749 | 0.130 |
Why?
|
Silicones | 1 | 2017 | 228 | 0.130 |
Why?
|
Cell Membrane Permeability | 1 | 2017 | 568 | 0.130 |
Why?
|
Succinimides | 1 | 2015 | 83 | 0.130 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2016 | 136 | 0.130 |
Why?
|
Cell Adhesion | 4 | 2014 | 3093 | 0.130 |
Why?
|
Piperidines | 1 | 2024 | 1663 | 0.120 |
Why?
|
Biophysical Phenomena | 2 | 2009 | 318 | 0.120 |
Why?
|
Chemokine CCL5 | 1 | 2015 | 214 | 0.120 |
Why?
|
Median Eminence | 1 | 2014 | 28 | 0.120 |
Why?
|
Prostaglandins | 1 | 2015 | 398 | 0.120 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2015 | 220 | 0.120 |
Why?
|
Disease Models, Animal | 8 | 2018 | 18329 | 0.120 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 588 | 0.120 |
Why?
|
Cromolyn Sodium | 1 | 2014 | 76 | 0.120 |
Why?
|
Liver Function Tests | 1 | 2016 | 527 | 0.120 |
Why?
|
Confined Spaces | 1 | 2014 | 10 | 0.110 |
Why?
|
Chemokine CXCL12 | 2 | 2014 | 457 | 0.110 |
Why?
|
Anti-Bacterial Agents | 3 | 2019 | 7475 | 0.110 |
Why?
|
Leukotrienes | 1 | 2015 | 232 | 0.110 |
Why?
|
Cyclic N-Oxides | 1 | 2014 | 71 | 0.110 |
Why?
|
Cell Count | 2 | 2016 | 1826 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2016 | 4410 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2022 | 1172 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2018 | 1525 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2020 | 1163 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1852 | 0.110 |
Why?
|
Kidney Function Tests | 1 | 2016 | 685 | 0.110 |
Why?
|
Neoplastic Stem Cells | 2 | 2020 | 1349 | 0.110 |
Why?
|
Cell Nucleolus | 1 | 2014 | 156 | 0.110 |
Why?
|
Microbial Sensitivity Tests | 2 | 2018 | 1972 | 0.110 |
Why?
|
rho GTP-Binding Proteins | 2 | 2013 | 279 | 0.110 |
Why?
|
Cell Differentiation | 4 | 2021 | 11657 | 0.110 |
Why?
|
Middle Aged | 13 | 2025 | 223267 | 0.110 |
Why?
|
Microvessels | 2 | 2015 | 586 | 0.110 |
Why?
|
Chemokines | 1 | 2018 | 963 | 0.110 |
Why?
|
Female | 29 | 2025 | 396532 | 0.110 |
Why?
|
Nerve Growth Factors | 1 | 2016 | 564 | 0.110 |
Why?
|
Coloring Agents | 1 | 2016 | 565 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3343 | 0.110 |
Why?
|
Antigens | 2 | 2015 | 1442 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2018 | 1244 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1600 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2024 | 8623 | 0.100 |
Why?
|
Hydrodynamics | 1 | 2013 | 164 | 0.100 |
Why?
|
Pancreatic Elastase | 1 | 2012 | 124 | 0.100 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2012 | 56 | 0.100 |
Why?
|
Dynamins | 1 | 2013 | 141 | 0.100 |
Why?
|
Golgi Apparatus | 1 | 2014 | 406 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 903 | 0.100 |
Why?
|
Microscopy, Phase-Contrast | 2 | 2009 | 110 | 0.100 |
Why?
|
Spin Labels | 1 | 2014 | 334 | 0.100 |
Why?
|
Laminin | 1 | 2014 | 404 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5690 | 0.100 |
Why?
|
Lymphocyte Count | 1 | 2014 | 794 | 0.100 |
Why?
|
Anisotropy | 1 | 2015 | 1286 | 0.100 |
Why?
|
Myosin Light Chains | 2 | 2022 | 121 | 0.100 |
Why?
|
Calibration | 2 | 2004 | 814 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1794 | 0.100 |
Why?
|
Microchip Analytical Procedures | 1 | 2011 | 28 | 0.100 |
Why?
|
Micro-Electrical-Mechanical Systems | 1 | 2011 | 28 | 0.100 |
Why?
|
Point-of-Care Systems | 2 | 2011 | 1217 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2016 | 22351 | 0.100 |
Why?
|
Biological Transport, Active | 1 | 2012 | 323 | 0.100 |
Why?
|
Random Allocation | 1 | 2016 | 2394 | 0.090 |
Why?
|
Cystic Fibrosis | 1 | 2021 | 1285 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2017 | 865 | 0.090 |
Why?
|
HIV Seropositivity | 2 | 2007 | 962 | 0.090 |
Why?
|
Equipment Failure Analysis | 2 | 2016 | 832 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8928 | 0.090 |
Why?
|
Mycobacterium smegmatis | 1 | 2011 | 126 | 0.090 |
Why?
|
Temperature | 4 | 2009 | 2231 | 0.090 |
Why?
|
CD4 Lymphocyte Count | 2 | 2007 | 2586 | 0.090 |
Why?
|
Mice, Transgenic | 7 | 2021 | 9546 | 0.090 |
Why?
|
Proteoglycans | 1 | 2014 | 806 | 0.090 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2010 | 203 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1089 | 0.090 |
Why?
|
Pressure | 1 | 2013 | 1172 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 605 | 0.090 |
Why?
|
Thrombosis | 2 | 2016 | 2953 | 0.090 |
Why?
|
Receptors, CXCR3 | 1 | 2011 | 240 | 0.090 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 1960 | 0.090 |
Why?
|
Lymphocytes | 1 | 2018 | 2606 | 0.090 |
Why?
|
Cell Migration Inhibition | 2 | 2008 | 97 | 0.090 |
Why?
|
Particle Size | 3 | 2008 | 1633 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2882 | 0.080 |
Why?
|
GTP Phosphohydrolases | 1 | 2013 | 525 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2021 | 3468 | 0.080 |
Why?
|
Kinetics | 4 | 2009 | 6288 | 0.080 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2010 | 120 | 0.080 |
Why?
|
Eukaryota | 1 | 2010 | 101 | 0.080 |
Why?
|
Nocodazole | 1 | 2009 | 95 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4652 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2018 | 2875 | 0.080 |
Why?
|
Surface Properties | 2 | 2009 | 1153 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3213 | 0.080 |
Why?
|
Nucleic Acid Denaturation | 1 | 2009 | 111 | 0.080 |
Why?
|
Cell-Free System | 1 | 2009 | 339 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2017 | 1689 | 0.080 |
Why?
|
Adolescent | 8 | 2021 | 88902 | 0.080 |
Why?
|
Macrophages | 3 | 2022 | 5784 | 0.080 |
Why?
|
Antibody Affinity | 1 | 2009 | 251 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2016 | 1377 | 0.080 |
Why?
|
Biomimetic Materials | 1 | 2010 | 170 | 0.080 |
Why?
|
Axonal Transport | 1 | 2009 | 178 | 0.080 |
Why?
|
Cell Membrane | 2 | 2016 | 3642 | 0.080 |
Why?
|
Bandages | 1 | 2010 | 270 | 0.080 |
Why?
|
Infant, Newborn | 5 | 2021 | 26387 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1757 | 0.080 |
Why?
|
Ascitic Fluid | 1 | 2008 | 189 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2801 | 0.080 |
Why?
|
Exudates and Transudates | 1 | 2008 | 175 | 0.080 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 521 | 0.080 |
Why?
|
Antibodies | 1 | 2016 | 2421 | 0.080 |
Why?
|
Fractionation, Field Flow | 1 | 2007 | 3 | 0.080 |
Why?
|
Systems Biology | 1 | 2012 | 481 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2018 | 1857 | 0.070 |
Why?
|
Ectoderm | 1 | 2008 | 138 | 0.070 |
Why?
|
Glycerol | 1 | 2009 | 274 | 0.070 |
Why?
|
Aged | 8 | 2025 | 171344 | 0.070 |
Why?
|
Motion | 2 | 2008 | 783 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2120 | 0.070 |
Why?
|
Silicon | 1 | 2008 | 141 | 0.070 |
Why?
|
Genes, erbB-1 | 1 | 2008 | 161 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4401 | 0.070 |
Why?
|
Nuclear Envelope | 1 | 2008 | 161 | 0.070 |
Why?
|
Drug Approval | 1 | 2014 | 820 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2018 | 4215 | 0.070 |
Why?
|
Drug Combinations | 1 | 2014 | 2085 | 0.070 |
Why?
|
Filtration | 1 | 2008 | 227 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 980 | 0.070 |
Why?
|
Connexin 43 | 1 | 2008 | 202 | 0.070 |
Why?
|
Lymphocyte Activation | 2 | 2015 | 5502 | 0.070 |
Why?
|
Neoplasm Invasiveness | 2 | 2012 | 3610 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2815 | 0.070 |
Why?
|
Cell Extracts | 1 | 2007 | 134 | 0.070 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 267 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 11924 | 0.070 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21162 | 0.070 |
Why?
|
Gap Junctions | 1 | 2008 | 230 | 0.070 |
Why?
|
DNA, Neoplasm | 2 | 2010 | 1741 | 0.070 |
Why?
|
Oocytes | 1 | 2011 | 1168 | 0.070 |
Why?
|
E-Selectin | 1 | 2008 | 576 | 0.070 |
Why?
|
Bioreactors | 1 | 2007 | 244 | 0.070 |
Why?
|
Actins | 3 | 2022 | 2061 | 0.070 |
Why?
|
Receptors, Interleukin-8B | 1 | 2005 | 58 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2012 | 5795 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3702 | 0.060 |
Why?
|
Hemodynamics | 1 | 2016 | 4188 | 0.060 |
Why?
|
Mice, Nude | 1 | 2012 | 3618 | 0.060 |
Why?
|
Collagen | 1 | 2014 | 2635 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4626 | 0.060 |
Why?
|
Spectrum Analysis | 1 | 2007 | 443 | 0.060 |
Why?
|
Flow Cytometry | 6 | 2016 | 5890 | 0.060 |
Why?
|
Retroviridae | 1 | 2007 | 846 | 0.060 |
Why?
|
Embryonic Stem Cells | 2 | 2012 | 1244 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 2 | 2012 | 1664 | 0.060 |
Why?
|
Fibronectins | 1 | 2008 | 722 | 0.060 |
Why?
|
Miniaturization | 1 | 2005 | 151 | 0.060 |
Why?
|
Membrane Proteins | 3 | 2010 | 7869 | 0.060 |
Why?
|
Child | 6 | 2022 | 80670 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 996 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2006 | 420 | 0.060 |
Why?
|
Oxygen | 1 | 2016 | 4252 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1627 | 0.060 |
Why?
|
Microcirculation | 1 | 2008 | 1282 | 0.050 |
Why?
|
Phosphorylation | 3 | 2021 | 8310 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2013 | 1739 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2008 | 1130 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13644 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1814 | 0.050 |
Why?
|
Microspheres | 3 | 2013 | 774 | 0.050 |
Why?
|
Cholesterol | 1 | 2012 | 2904 | 0.050 |
Why?
|
GPI-Linked Proteins | 2 | 2017 | 472 | 0.050 |
Why?
|
Water | 1 | 2009 | 1416 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2006 | 557 | 0.050 |
Why?
|
Neoplasm Metastasis | 4 | 2020 | 4892 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 1132 | 0.050 |
Why?
|
Glycyrrhetinic Acid | 1 | 2002 | 15 | 0.050 |
Why?
|
Leukocyte Transfusion | 1 | 2022 | 58 | 0.050 |
Why?
|
Microscopy, Fluorescence | 4 | 2013 | 2629 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20146 | 0.050 |
Why?
|
Kidney Transplantation | 2 | 2015 | 4278 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3582 | 0.050 |
Why?
|
Monte Carlo Method | 2 | 2004 | 1251 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2015 | 3799 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2008 | 962 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2014 | 5143 | 0.050 |
Why?
|
RNA Interference | 1 | 2010 | 2829 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5444 | 0.050 |
Why?
|
Paclitaxel | 1 | 2009 | 1728 | 0.050 |
Why?
|
Metabolomics | 1 | 2011 | 1674 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2019 | 1562 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4504 | 0.050 |
Why?
|
Candidemia | 1 | 2022 | 46 | 0.050 |
Why?
|
Pulmonary Aspergillosis | 1 | 2022 | 48 | 0.050 |
Why?
|
Chemokine CXCL2 | 1 | 2021 | 105 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2021 | 22248 | 0.050 |
Why?
|
Neuroimmunomodulation | 1 | 2023 | 186 | 0.050 |
Why?
|
Cell Degranulation | 1 | 2022 | 276 | 0.050 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2021 | 187 | 0.050 |
Why?
|
Markov Chains | 1 | 2004 | 974 | 0.050 |
Why?
|
Biophysics | 1 | 2002 | 376 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2011 | 1911 | 0.040 |
Why?
|
Central Nervous System | 1 | 2008 | 1345 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2021 | 234 | 0.040 |
Why?
|
Antibodies, Neutralizing | 2 | 2021 | 2011 | 0.040 |
Why?
|
HIV | 1 | 2007 | 1588 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 136 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7073 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14073 | 0.040 |
Why?
|
Mutation | 4 | 2013 | 30214 | 0.040 |
Why?
|
Cell Surface Extensions | 1 | 2019 | 65 | 0.040 |
Why?
|
Cytoskeletal Proteins | 2 | 2019 | 1326 | 0.040 |
Why?
|
Transplants | 1 | 2021 | 209 | 0.040 |
Why?
|
Cryosurgery | 1 | 2004 | 479 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3942 | 0.040 |
Why?
|
Cell Adhesion Molecules | 2 | 2017 | 1612 | 0.040 |
Why?
|
Neuroglia | 1 | 2023 | 960 | 0.040 |
Why?
|
Myosins | 1 | 2019 | 407 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 3114 | 0.040 |
Why?
|
Actin-Related Protein 2 | 1 | 2017 | 40 | 0.040 |
Why?
|
Actin-Related Protein 3 | 1 | 2017 | 48 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.030 |
Why?
|
Carrier State | 1 | 2021 | 530 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 14653 | 0.030 |
Why?
|
Perfusion | 1 | 2022 | 1409 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3796 | 0.030 |
Why?
|
Proteomics | 1 | 2010 | 3915 | 0.030 |
Why?
|
Microscopy | 2 | 2014 | 902 | 0.030 |
Why?
|
Eosinophils | 1 | 2021 | 952 | 0.030 |
Why?
|
Optics and Photonics | 2 | 2008 | 305 | 0.030 |
Why?
|
Hepatocytes | 2 | 2017 | 1246 | 0.030 |
Why?
|
Embryo, Mammalian | 2 | 2014 | 1675 | 0.030 |
Why?
|
Neurofibrillary Tangles | 1 | 2018 | 457 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 54872 | 0.030 |
Why?
|
Specimen Handling | 2 | 2011 | 706 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2015 | 59548 | 0.030 |
Why?
|
Computer Simulation | 2 | 2008 | 6258 | 0.030 |
Why?
|
Flavonols | 1 | 2014 | 84 | 0.030 |
Why?
|
Models, Molecular | 1 | 2004 | 5388 | 0.030 |
Why?
|
Genomics | 1 | 2010 | 5922 | 0.030 |
Why?
|
Presenilin-1 | 1 | 2018 | 665 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4559 | 0.030 |
Why?
|
Antigens, CD | 2 | 2017 | 4033 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3343 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1244 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2030 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2022 | 2391 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 685 | 0.030 |
Why?
|
Osmosis | 1 | 2012 | 103 | 0.030 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2018 | 1117 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 1018 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15912 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2413 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 789 | 0.020 |
Why?
|
Thienamycins | 1 | 2011 | 29 | 0.020 |
Why?
|
Platelet Activating Factor | 1 | 2012 | 142 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3043 | 0.020 |
Why?
|
Swine | 1 | 2022 | 5985 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 899 | 0.020 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2011 | 48 | 0.020 |
Why?
|
Flavonoids | 1 | 2014 | 447 | 0.020 |
Why?
|
Receptors, CCR4 | 1 | 2011 | 77 | 0.020 |
Why?
|
Cycloserine | 1 | 2011 | 118 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12808 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2626 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3385 | 0.020 |
Why?
|
Platelet Adhesiveness | 1 | 2011 | 154 | 0.020 |
Why?
|
Host-Parasite Interactions | 1 | 2013 | 303 | 0.020 |
Why?
|
L-Selectin | 1 | 2011 | 212 | 0.020 |
Why?
|
Tubulin | 1 | 2014 | 694 | 0.020 |
Why?
|
Oxidants | 1 | 2011 | 168 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8734 | 0.020 |
Why?
|
Bacteriological Techniques | 1 | 2011 | 277 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4143 | 0.020 |
Why?
|
Protective Agents | 1 | 2011 | 150 | 0.020 |
Why?
|
Biotinylation | 1 | 2010 | 184 | 0.020 |
Why?
|
Isoniazid | 1 | 2011 | 279 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6105 | 0.020 |
Why?
|
Models, Statistical | 1 | 2004 | 5092 | 0.020 |
Why?
|
Formamides | 1 | 2009 | 22 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 16044 | 0.020 |
Why?
|
Rifampin | 1 | 2011 | 350 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5389 | 0.020 |
Why?
|
Dependovirus | 1 | 2014 | 720 | 0.020 |
Why?
|
Blood Cells | 1 | 2011 | 309 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2012 | 663 | 0.020 |
Why?
|
Diffusion Chambers, Culture | 1 | 2008 | 49 | 0.020 |
Why?
|
Biomedical Engineering | 1 | 2010 | 284 | 0.020 |
Why?
|
Plectin | 1 | 2008 | 14 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 1751 | 0.020 |
Why?
|
Emulsions | 1 | 2009 | 150 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5022 | 0.020 |
Why?
|
Adhesiveness | 1 | 2008 | 52 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1331 | 0.020 |
Why?
|
Cell Wall | 1 | 2011 | 419 | 0.020 |
Why?
|
Amides | 1 | 2011 | 451 | 0.020 |
Why?
|
Polystyrenes | 1 | 2008 | 102 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2011 | 10451 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36459 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10745 | 0.020 |
Why?
|
Crystallization | 1 | 2009 | 518 | 0.020 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2008 | 122 | 0.020 |
Why?
|
Vimentin | 1 | 2008 | 257 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42577 | 0.020 |
Why?
|
Fermentation | 1 | 2008 | 143 | 0.020 |
Why?
|
Dimethylpolysiloxanes | 1 | 2008 | 142 | 0.020 |
Why?
|
High Mobility Group Proteins | 1 | 2008 | 179 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2954 | 0.020 |
Why?
|
Rheology | 1 | 2008 | 347 | 0.020 |
Why?
|
Integrins | 1 | 2012 | 839 | 0.020 |
Why?
|
Mesoderm | 1 | 2010 | 679 | 0.020 |
Why?
|
Thermodynamics | 1 | 2009 | 580 | 0.020 |
Why?
|
Hemorheology | 1 | 2007 | 144 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2009 | 781 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8890 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2010 | 13489 | 0.020 |
Why?
|
Monitoring, Immunologic | 1 | 2007 | 99 | 0.020 |
Why?
|
Viscosity | 1 | 2007 | 334 | 0.020 |
Why?
|
Urea | 1 | 2009 | 449 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2014 | 822 | 0.020 |
Why?
|
Models, Chemical | 1 | 2008 | 607 | 0.020 |
Why?
|
Peritonitis | 1 | 2008 | 368 | 0.020 |
Why?
|
Cell Shape | 1 | 2007 | 372 | 0.020 |
Why?
|
SOXB1 Transcription Factors | 1 | 2008 | 283 | 0.020 |
Why?
|
Coated Materials, Biocompatible | 1 | 2008 | 314 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4277 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1673 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 1767 | 0.020 |
Why?
|
DNA | 2 | 2010 | 7210 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3564 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 655 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 2005 | 176 | 0.020 |
Why?
|
Rotation | 1 | 2007 | 514 | 0.020 |
Why?
|
Th1 Cells | 1 | 2011 | 1040 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2014 | 81657 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2006 | 361 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10580 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2006 | 524 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3776 | 0.020 |
Why?
|
Th2 Cells | 1 | 2011 | 1077 | 0.020 |
Why?
|
Pseudopodia | 1 | 2005 | 168 | 0.020 |
Why?
|
Response Elements | 1 | 2006 | 308 | 0.020 |
Why?
|
Huntington Disease | 1 | 2012 | 1147 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1198 | 0.010 |
Why?
|
Down-Regulation | 1 | 2012 | 2931 | 0.010 |
Why?
|
Cell Division | 1 | 2011 | 4473 | 0.010 |
Why?
|
Graft Survival | 1 | 2015 | 3904 | 0.010 |
Why?
|
Genotype | 2 | 2009 | 13036 | 0.010 |
Why?
|
Ovalbumin | 1 | 2006 | 677 | 0.010 |
Why?
|
Sirolimus | 1 | 2011 | 1540 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4570 | 0.010 |
Why?
|
Receptors, CCR5 | 1 | 2006 | 491 | 0.010 |
Why?
|
Protein Transport | 1 | 2009 | 1944 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18397 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2925 | 0.010 |
Why?
|
Embryonic Development | 1 | 2008 | 722 | 0.010 |
Why?
|
Proteome | 1 | 2013 | 1894 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2011 | 3157 | 0.010 |
Why?
|
Electric Impedance | 1 | 2007 | 791 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1608 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2006 | 827 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1969 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2006 | 1352 | 0.010 |
Why?
|
HeLa Cells | 1 | 2008 | 3073 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2603 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9244 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2005 | 1472 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3759 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 2008 | 807 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5755 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 2006 | 729 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2005 | 1206 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26309 | 0.010 |
Why?
|
United States | 2 | 2022 | 72945 | 0.010 |
Why?
|
HIV Antibodies | 1 | 2007 | 1337 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9358 | 0.010 |
Why?
|
HIV Infections | 1 | 2006 | 17532 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4114 | 0.010 |
Why?
|
Virus Replication | 1 | 2007 | 2457 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12415 | 0.010 |
Why?
|
Escherichia coli | 1 | 2011 | 4211 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2008 | 1399 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3789 | 0.010 |
Why?
|
Cell Lineage | 1 | 2008 | 2573 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1802 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2270 | 0.010 |
Why?
|
Cancer Vaccines | 1 | 2006 | 1042 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41706 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9514 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6514 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12795 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2006 | 2571 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 2006 | 1503 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 8108 | 0.010 |
Why?
|
Glioma | 1 | 2009 | 3498 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12536 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2009 | 5753 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14473 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13642 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9613 | 0.010 |
Why?
|
Pregnancy | 1 | 2011 | 30236 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29959 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2015 | 65286 | 0.000 |
Why?
|
Hospitalization | 1 | 2008 | 10816 | 0.000 |
Why?
|
Risk Factors | 1 | 2015 | 74889 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11094 | 0.000 |
Why?
|
Transcription Factors | 1 | 2006 | 12159 | 0.000 |
Why?
|